HomeCompareHJLI vs YUM

HJLI vs YUM: Dividend Comparison 2026

HJLI yields 19.27% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YUM wins by $37.2K in total portfolio value· pulled ahead in Year 9
10 years
HJLI
HJLI
● Live price
19.27%
Share price
$10.38
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$69.8K
Annual income
$6,227.54
Full HJLI calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — HJLI vs YUM

📍 YUM pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHJLIYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HJLI + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HJLI pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HJLI
Annual income on $10K today (after 15% tax)
$1,637.76/yr
After 10yr DRIP, annual income (after tax)
$5,293.41/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, YUM beats the other by $28,670.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HJLI + YUM for your $10,000?

HJLI: 50%YUM: 50%
100% YUM50/50100% HJLI
Portfolio after 10yr
$88.4K
Annual income
$23,092.43/yr
Blended yield
26.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

HJLI
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
14.9
Piotroski
3/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HJLI buys
0
YUM buys
0
No recent congressional trades found for HJLI or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHJLIYUM
Forward yield19.27%1.85%
Annual dividend / share$2.00$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$69.8K$107.0K
Annual income after 10y$6,227.54$39,957.33
Total dividends collected$38.9K$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyHold

Year-by-year: HJLI vs YUM ($10,000, DRIP)

YearHJLI PortfolioHJLI Income/yrYUM PortfolioYUM Income/yrGap
1$12,627$1,926.78$10,980$280.44+$1.6KHJLI
2$15,784$2,273.74$12,185$435.72+$3.6KHJLI
3$19,546$2,656.40$13,722$684.14+$5.8KHJLI
4$23,988$3,074.20$15,773$1,090.14+$8.2KHJLI
5$29,193$3,526.09$18,650$1,773.02+$10.5KHJLI
6$35,247$4,010.50$22,921$2,966.37+$12.3KHJLI
7$42,240$4,525.40$29,685$5,158.69+$12.6KHJLI
8$50,265$5,068.41$41,216$9,453.02+$9.0KHJLI
9← crossover$59,421$5,636.78$62,672$18,571.31$3.3KYUM
10$69,808$6,227.54$107,016$39,957.33$37.2KYUM

HJLI vs YUM: Complete Analysis 2026

HJLIStock

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.

Full HJLI Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this HJLI vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HJLI vs SCHDHJLI vs JEPIHJLI vs OHJLI vs KOHJLI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.